US Based Munchkin were going after exclusive "grass fed" registration (ie grass only no barns or grains).
Synlait had invested quite heavily in the process but for some reason Munchkin pulled the plug. Registration for their infant product was going to be a very onerous process. I recall they pulled the plug part way through clinical trials.
It does give an indication of how difficult it is to get infant formula registered - something A2 wil be aware of.
And given Abbots problems I can't see the US being too keen to fast track approvals if there is any risk to this consumer demographic.
A2M Confirms its also submitted applications for FDA sales approvals in USA, page-12
-
- There are more pages in this discussion • 100 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add A2M (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$6.88 |
Change
0.000(0.00%) |
Mkt cap ! $4.973B | |||
| Open | High | Low | Value | Volume |
| $6.90 | $6.90 | $6.80 | $7.266M | 1.060M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 12501 | $6.87 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $6.88 | 33092 | 3 |
View Market Depth
| Last trade - 16.10pm 12/07/2024 (20 minute delay) ? |
| A2M (ASX) Chart |